ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
iShares Global Healthcare

iShares Global Healthcare (IXJ)

91.95
-0.39
(-0.42%)
Cerrado 23 Marzo 2:00PM
90.32
-1.63
(-1.77%)
Fuera de horario: 3:43PM

Calls

StrikeCompraVentaUltimo PrecioP. MedioVariaciónVariación %VolumeInt AbiertoÚltimo Operado
88.000.000.000.000.000.000.00 %00-
89.001.305.100.003.200.000.00 %00-
90.000.000.000.000.000.000.00 %00-
91.000.000.000.000.000.000.00 %00-
92.000.000.000.000.000.000.00 %00-
93.000.000.000.000.000.000.00 %00-
94.000.002.550.000.000.000.00 %00-
95.000.000.000.000.000.000.00 %00-
96.000.000.000.000.000.000.00 %00-

Herramientas de nivel profesional para inversores individuales.

Puts

StrikeCompraVentaUltimo PrecioP. MedioVariaciónVariación %VolumeInt AbiertoÚltimo Operado
88.000.000.000.000.000.000.00 %00-
89.000.000.000.000.000.000.00 %00-
90.001.002.651.001.8250.000.00 %01-
91.000.003.000.000.000.000.00 %00-
92.000.003.300.000.000.000.00 %00-
93.000.000.000.000.000.000.00 %00-
94.000.453.900.002.1750.000.00 %00-
95.000.000.000.000.000.000.00 %00-
96.002.706.500.004.600.000.00 %00-

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
SGLYSingularity Future Technology Ltd
US$ 1.6799
(143.43%)
30.76M
VVPRVivoPower International PLC
US$ 1.2899
(52.13%)
62.33M
RNAZTransCode Therapeutics Inc
US$ 1.12
(45.45%)
215.3M
GLTOGalecto Inc
US$ 6.00
(44.93%)
10.71M
XHLDTEN Holdings Inc
US$ 1.44
(44.38%)
58.43M
YHCLQR House Inc
US$ 0.40
(-82.38%)
38.32M
KZIAKazia Therapeutics Ltd
US$ 0.9759
(-80.02%)
55.66k
DMNDamon Inc
US$ 0.0373
(-70.02%)
304.17M
TCBPTC BioPharm Holdings PLC
US$ 0.5046
(-67.23%)
5.9M
SOWGSow Good Inc
US$ 1.53
(-44.36%)
698.02k
DMNDamon Inc
US$ 0.0373
(-70.02%)
304.17M
NVDANVIDIA Corporation
US$ 117.70
(-0.70%)
264.42M
RNAZTransCode Therapeutics Inc
US$ 1.12
(45.45%)
216.22M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9.03
(10.66%)
175.77M
HOLOMicroCloud Hologram Inc
US$ 1.00
(32.36%)
141.98M
$2.00 or no deal $2.00 or no deal 3 minutos hace
Nice...

Repeal the Mikah Tax -- To be paid by all shareholders at buyout
1. Cost of Second Tier Suitors
2. Cost of Secret Side Deal with Hakim
3. Cost of Mikah litigation
4. Cost of remaining OTC
ELTP
$2.00 or no deal $2.00 or no deal 4 minutos hace
All the BE studies failed last year.

Nasrat lied to us when said QUOTE "At least two ANDA's will be filed in 2024".

And he said one of these was the CNS product (Concerta).

I’d like Elite to expand their portfolio. The best way is having ANDA’s approved.
ELTP
$2.00 or no deal $2.00 or no deal 8 minutos hace
You mean Kirko...

Nasrat was all in years ago and deserves both the credit and the rewards for making this company a force in the generic drug field.
ELTP
Truenorth2016 Truenorth2016 15 minutos hace
Also Stervc, GCAN CEO Aitan keeps emphasizing in Core Gaming Pr's and the merger video, this:

"Core Gaming has developed cutting edge AI tools using text, language, image and video models to achieve a 50% boost in content production, reducing production time by over 40%, and significa
GCAN
Peter J Peter J 16 minutos hace
Well...HELLO mr fung derf...

LET'S WELCOME A NEW MEMBER TO THE ALTRUIST GANG... 🤣

However, my answer is, I don't care about what is posted if its not intended to hurt others
ERHE
Polymer Paul Polymer Paul 17 minutos hace
This is good.... So you now know that when Yves says 18-24 months for results... He means 18-24 months !!! Long time off that Belgium ... Very long time in the stock world. Good luck with that
LWLG
$2.00 or no deal $2.00 or no deal 18 minutos hace
EVERYONE CARES about what happened 10 years ago!

NO ONE CARES about what happened 10 years ago!
ELTP
$2.00 or no deal $2.00 or no deal 19 minutos hace
Agreed!

Hakim is a miserable failure when it comes to fulfilling his fiduciary duty to Elite shareholders.
ELTP
Peter J Peter J 19 minutos hace
Still posting, mr. 6503 posts? While having no financial interest here... 🤣
https://investorshub.advfn.com/boards/profileb.aspx?user=44043
ERHE
$2.00 or no deal $2.00 or no deal 20 minutos hace
He's been horrible.

Nasrat has been an amazing CEO for investors that have held their shares.
ELTP
Wayne R Wayne R 21 minutos hace
Last month was last month, this is this month and they just voted for another this month.

Sure, I know it is hard to keep track....
MULN
BDEZ BDEZ 30 minutos hace
LBJ Talks About Shooting Methamphetamine with Jackie Kennedy in Newly Released Presidential Phone Call

https://x.com/RealAlexJones/status/1903544281098330461
Truenorth2016 Truenorth2016 32 minutos hace
In Our Face Stervc!! NVDA and Core Gaming has the same tech and this is why GCAN CEO Aitan Zacharin keep saying his company is going to soon be the Number One "AI Gaming" Company in the world...... AITAN has something up his sleeve.....he knows he has tech that no one else has or has an edge on othe
GCAN NVDA
SkeBallLarry SkeBallLarry 33 minutos hace
Now there's a good one, Trin .. !!!
Investor2014 Investor2014 36 minutos hace
In the current context and considering Missling is from Europe, where approval is sought from EMA. Anavex have run only one tiny adult Rett trial in the U.S., all other trials have been run in countries collaborating with Europe. Considering all this - the Anavex HQ may not be in NYC or anywhere clo
AVXL
BDEZ BDEZ 43 minutos hace
Foreman was a prominent promoter of the jab. Even doing paid commercials

https://x.com/RealAlexJones/status/1903397708368404556
Flexplate Flexplate 48 minutos hace
Live Update At 09:18:06 EST: On Friday, March 21, 2025 TransCode Therapeutics Inc. stock [NASDAQ: RNAZ] is trending up by 34.42%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

TransCode Therapeutics received a nod to proc
RNAZ
cleanerworldwehope cleanerworldwehope 52 minutos hace
Scancell announces further positive data from the ongoing SCOPE trial of SCIB1 with double CPIs for Advanced
Melanoma
80% Progression Free Survival in 25 patients at 6 months
20% (5) patients have shown a complete response following treatment
Disease Control Rate of 84% a
MRNA
janice shell janice shell 53 minutos hace
I think perhaps he should report it to his carrier as phishing. That might make it go away. At least for a while.
Flexplate Flexplate 53 minutos hace
The amount of bullish sentiment on this is insane. One of the other chat pages I'm on has gained over 900 new followers on RNAZ since Fridays close. Monday this is going to run hard!
RNAZ
Investor2014 Investor2014 55 minutos hace
You misunderstood Hoskuld’s sentence, go back, read and think.
AVXL
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 56 minutos hace
I want this stock to go UP. It just never does.

But you said it went up 31 cents this week!

please explain
AVXL
cleanerworldwehope cleanerworldwehope 57 minutos hace
Moderna/Merck’s Phase 3 trial (V940-001, NCT05933577) is expected to enroll ~1,089 patients
SCNLF

Su Consulta Reciente

Delayed Upgrade Clock